4-Butyl-pentamethylensulfon | 70928-51-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻烷
• 英文名称: 4-Butyl-pentamethylensulfon
• 英文别名: 4-butyl-tetrahydro-thiopyran 1,1-dioxide；4-n-Butylthiane, S,S-dioxide；4-butylthiane 1,1-dioxide
• CAS: 70928-51-7
• 化学式: C₉H₁₈O₂S
• 分子量: 190.307
• InChiKey: MXSMSEPXNOAEDL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  γ-n-Butylpentamethylensulfid 、 双氧水 以100%的产率得到
  参考文献：
  名称：

  VOLYNSKIJ N. P.; SHCHERBAKOVA L. P., IZV. AN CCCP. CEP. XIM., 1979, HO 5, 1077-1080

  摘要：

  DOI：

文献信息

• Polycarbonate resin composition
  申请人：MITSUBISHI ENGINEERING-PLASTICS CORPORATION

  公开号：EP0753540A2

  公开（公告）日：1997-01-15

  A polycarbonate resin composition according to the present invention is suited to be used for medical supplies or appliances and shows a very low yellow discoloration when exposed to an ionizing radiation for sterilization. The polycarbonate resin composition comprises 100 parts by weight of a polycarbonate resin; 0.01 to 5 parts by weight of an aromatic compound containing oxy group or carbonyl group; and 0.01 to 5 parts by weight of at least one compound selected from the group consisting of: (A) a compound containing cyclic acetal group; (B) a sulfone compound; (C) a sulfoxide compound; (D) polyalkylene glycol, an ether of polyalkylene glycol or an ester of polyalkylene glycol; (E) a compound containing sulfonate group; and (F) an aromatic hydrocarbon-aldehyde resin.

  根据本发明的一种聚碳酸酯树脂组合物适合用于医疗用品或器具，在暴露于电离辐射灭菌时，黄色褪色程度很低。聚碳酸酯树脂组合物包括 100 重量份的聚碳酸酯树脂；0.01 至 5 重量份的含氧基或羰基的芳香族化合物；以及 0.(A) 含环缩醛基团的化合物；(B) 砜化合物；(C) 亚砜化合物；(D) 聚亚烷基二醇、聚亚烷基二醇的醚或聚亚烷基二醇的酯；(E) 含磺酸基团的化合物；(F) 芳香烃-醛树脂。
• Polycarbonate resin composition stabilized against radiation
  申请人：MITSUBISHI ENGINEERING-PLASTICS CORPORATION

  公开号：EP0794218A2

  公开（公告）日：1997-09-10

  The present invention relates to a polycarbonate resin composition comprising 100 parts by weight of a polycarbonate resin; 0.01 to 5 parts by weight of a compound containing oxymethylene unit, a compound containing oxymethylene unit having substituent or a cyclic ether compound having substituent.

  本发明涉及一种聚碳酸酯树脂组合物，该组合物包括 100 重量份的聚碳酸酯树脂； 0.01 至 5 重量份的含氧亚甲基单元的化合物、含氧亚甲基单元且具有取代基的化合物或 具有取代基的环醚化合物。
• Thermoplastic resin composition
  申请人：——

  公开号：US20010034419A1

  公开（公告）日：2001-10-25

  A thermoplastic resin composition comprising: a transparent aromatic thermoplastic resin (a) and a copolyester resin (b) comprising at least two kinds of dicarboxylic acid moieties and one kind of diol moiety, 1 to 50 mol % of the dicarboxylic acid moieties being a naphthalenedicarboxylic acid moiety, the ratio of (a) to the combined amount of (a) and (b) being 55 to 99.99% by weight, and the ratio of (b) being 0.01 to 45% by weight.

  一种热塑性树脂组合物，包括 透明芳香族热塑性树脂（a）和 由至少两种二羧酸分子和一种二元醇分子组成的共聚酯树脂（b），其中 1 至 50 摩尔%的二羧酸分子为萘二甲酸分子、 按重量计，(a)与(a)和(b)的总和之比为 55%至 99.99%，(b)之比为 0.01%至 45%。
• AZADECALIN DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
  申请人：ViiV Healthcare UK (No.5) Limited

  公开号：EP3478662B1

  公开（公告）日：2020-09-16
• PKM2 MODULATORS AND METHODS FOR THEIR USE
  申请人：Tolero Pharmaceuticals, Inc.

  公开号：US20170015631A1

  公开（公告）日：2017-01-19

  Compounds having activity as PKM2 activators are disclosed. The compounds have the following structure (I): including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.